Viewing Study NCT00759759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-01-24 @ 5:58 PM
Study NCT ID: NCT00759759
Status: COMPLETED
Last Update Posted: 2010-08-17
First Post: 2008-09-24
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions
Sponsor: Actavis Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence View
None morphine sulfate sustained release capsules View
None KADIAN capsules View
None 200 mg View